{"data":{"ModuleTitle":{"label":"Module Title","value":"Company Description"},"CompanyName":{"label":"Company Name","value":"Jaguar Health, Inc."},"Symbol":{"label":"Symbol","value":"JAGX"},"Address":{"label":"Address","value":"200 PINE STREET,SUITE 400, SAN FRANCISCO, California, 94104, United States"},"Phone":{"label":"Phone","value":"+1 415 371-8300"},"Industry":{"label":"Industry","value":"Biotechnology: Pharmaceutical Preparations"},"Sector":{"label":"Sector","value":"Health Care"},"Region":{"label":"Region","value":"North America"},"CompanyDescription":{"label":"Company Description","value":"Jaguar Health Inc is a commercial-stage pharmaceuticals company focused on developing novel, plant-based, non-opioid, and sustainably derived prescription medicines for people and animals with GI distress, specifically chronic, debilitating diarrhea. Its product Mytesi is a novel, first-in-class anti-secretory agent which has a basic normalizing effect locally on the gut, and this mechanism of action has the potential to benefit multiple disorders."},"CompanyUrl":{"label":"Company Url","value":"http://www.jaguar.health"},"KeyExecutives":{"label":"Key Executives","value":[{"name":"Darlene P. Horton","title":"Chief Medical Officer"},{"name":"Lisa A. Conte","title":"President, Chief Executive Officer & Director"},{"name":"Pravin Ramsewak Chaturvedi","title":"Chief Scientific Officer"}]}},"message":null,"status":{"rCode":200,"bCodeMessage":null,"developerMessage":null}}